Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T73756 | Target Info | |||
Target Name | Ephrin type-B receptor 2 (EPHB2) | ||||
Synonyms |
hEK5; Tyrosine-protein kinase receptor EPH-3; Tyrosine-protein kinase TYRO5; TYRO5; Renal carcinoma antigen NY-REN-47; Receptor protein-tyrosine kinase HEK5; EphB2 receptor tyrosine kinase; EphB2; EPTH3; EPHT3; EPH-like kinase 5; EPH tyrosine kinase 3; ELK-related tyrosine kinase; EK5; Developmentally-regulated Eph-related tyrosine kinase; DRT
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | EPHB2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | ||||
UniProt ID | MK01_HUMAN | |||||
Gene Name | MAPK1 | |||||
Synonyms |
PRKM2; PRKM1; P42-MAPK; P42 Mitogen-activated protein kinase; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; MAPK 2; MAPK 1; MAP kinase isoform p42; MAP kinase 2; MAP kinase 1; ERT1; ERK-2
Click to Show/Hide
|
|||||
Representative Drug(s) | BVD-523 | Drug Info | IC50 = 0.03 nM | Click to Show More | [1] | |
2 | MK-8353 | Drug Info | IC50 = 7 nM | [2] | ||
Co-Target Name | Extracellular signal-regulated kinase 1 (ERK1) | Clinical trial Target | ||||
UniProt ID | MK03_HUMAN | |||||
Gene Name | MAPK3 | |||||
Synonyms |
PRKM3; P44-MAPK; P44-ERK1; P44 Mitogen-activated protein kinase; Mitogen-activated protein kinase 3; Microtubule-associated protein-2 kinase; Microtubule-associated protein 2 kinase; MAPK 3; MAP kinase isoform p44; MAP kinase 3; Insulin-stimulated MAP2 kinase; ERT2; ERK-1
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-8353 | Drug Info | IC50 = 20 nM | [2] | ||
Co-Target Name | Mitogen-activated protein kinase 1 (MAPK1) | Co-Target | ||||
UniProt ID | MK01_HUMAN | |||||
Gene Name | MAPK1 | |||||
Synonyms |
MAP kinase 1; MAPK 1; ERT1; Extracellular signal-regulated kinase 2; ERK-2; MAP kinase isoform p42; p42-MAPK; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2
Click to Show/Hide
|
|||||
Representative Drug(s) | BVD-523 | Drug Info | IC50 = 140 nM | [3] | ||
Co-Target Name | Mitogen-activated protein kinase 3 (MAPK3) | Co-Target | ||||
UniProt ID | MK03_HUMAN | |||||
Gene Name | MAPK3 | |||||
Synonyms |
MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1
Click to Show/Hide
|
|||||
Representative Drug(s) | BVD-523 | Drug Info | IC50 = 140 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase. Bioorg Med Chem Lett. 2015 Sep 15;25(18):3788-92. | ||||
REF 2 | MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology. ACS Med Chem Lett. 2018 Jun 14;9(7):761-7. | ||||
REF 3 | Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2. J Med Chem. 2015 Jun 11;58(11):4790-801. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.